Trials / Completed
CompletedNCT01142960
Effects of Lycium Barbarum Supplements on the Progression of Senile Cataract in Hong Kong Chinese Population
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 238 (actual)
- Sponsor
- The Hong Kong Polytechnic University · Academic / Other
- Sex
- All
- Age
- 60 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
With the rapid growing aging population, age-related eye diseases including cataract are becoming more prevalent. The demand for cataract surgery and post-surgical care posed enormous financial burdens to the government. Lycium barbarum contains lutein and zeaxanthin which can filter the phototoxic blue light and neutralize the reactive oxygen species, thus provide a protective effect against cataract formation. This study aims to determine the effects of Lycium barbarum Supplements on the progression of senile cataract in Hong Kong Chinese elderly.
Detailed description
Please note that a manuscript for this study is being prepared. Detailed description will be provided after we come up with the final draft.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Starch | 1350mg/day |
| DIETARY_SUPPLEMENT | Lycium Barbarum | 1350mg/day |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2012-04-01
- Completion
- 2012-06-01
- First posted
- 2010-06-14
- Last updated
- 2016-05-12
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT01142960. Inclusion in this directory is not an endorsement.